19-49007059-A-G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_006666.3(RUVBL2):āc.307A>Gā(p.Ile103Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000496 in 1,613,070 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_006666.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RUVBL2 | NM_006666.3 | c.307A>G | p.Ile103Val | missense_variant | 5/15 | ENST00000595090.6 | |
RUVBL2 | NM_001321190.2 | c.205A>G | p.Ile69Val | missense_variant | 5/15 | ||
RUVBL2 | NM_001321191.1 | c.172A>G | p.Ile58Val | missense_variant | 5/15 | ||
RUVBL2 | NR_135578.2 | n.332A>G | non_coding_transcript_exon_variant | 5/15 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RUVBL2 | ENST00000595090.6 | c.307A>G | p.Ile103Val | missense_variant | 5/15 | 1 | NM_006666.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152264Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000242 AC: 6AN: 247760Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135016
GnomAD4 exome AF: 0.0000534 AC: 78AN: 1460806Hom.: 0 Cov.: 32 AF XY: 0.0000564 AC XY: 41AN XY: 726698
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152264Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74392
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 28, 2022 | The c.307A>G (p.I103V) alteration is located in exon 5 (coding exon 5) of the RUVBL2 gene. This alteration results from a A to G substitution at nucleotide position 307, causing the isoleucine (I) at amino acid position 103 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at